Swedish Electronic Equipment and Components Stock News

OM:YUBICO
OM:YUBICOSoftware

Yubico (OM:YUBICO) Net Margin Compression Challenges Bullish Growth Narratives

Yubico (OM:YUBICO) FY 2025 earnings snapshot Yubico (OM:YUBICO) has wrapped up FY 2025 with Q4 revenue of 548.3 million SEK and basic EPS of 0.04 SEK, setting the tone for a year where trailing 12 month revenue came in at 2.2 billion SEK and basic EPS was 1.49 SEK. The company has seen quarterly revenue move between 499.1 million SEK and 623.1 million SEK over the past year, with basic EPS ranging from 0.04 SEK to 0.74 SEK. Trailing 12 month EPS and net income have tracked alongside 12 month...
OM:VSURE
OM:VSURECommercial Services

Verisure (OM:VSURE) Q4 Loss Worsens To €121.3m Challenging Bullish Profitability Narratives

Verisure (OM:VSURE) FY 2025 Earnings Snapshot Verisure (OM:VSURE) has wrapped up FY 2025 with fourth quarter revenue of €964.7 million and a basic EPS loss of €0.12, while trailing 12 month figures show revenue of about €3.7 billion and a basic EPS loss of €0.30. Over the past year, the company has seen revenue move from €870.2 million in Q4 2024 to €964.7 million in Q4 2025, while quarterly EPS stayed in loss making territory, shifting from a €0.07 loss per share in Q4 2024 to a €0.12 loss...
OM:CAMX
OM:CAMXPharmaceuticals

Why Camurus (OM:CAMX) Is Down 24.8% After Lifting 2026 Guidance and Showcasing Oxyesa Progress

Camurus AB reported its fourth-quarter and full-year 2025 results, with full-year sales rising to SEK 2,265.38 million and net income to SEK 735.57 million, while issuing 2026 guidance for revenues of SEK 2.60–2.90 billion and operating result of SEK 0.90–1.20 billion. Alongside these results, Camurus highlighted 2025 milestones including EU and UK approvals for Oxyesa in acromegaly and progress in long-acting metabolic therapies, underlining how its product pipeline and regulatory traction...
OM:ZZ B
OM:ZZ BRetail Distributors

3 European Dividend Stocks Offering Up To 5.5% Yield

As the European market continues to show resilience amidst global volatility, with the pan-European STOXX Europe 600 Index reaching new highs and major indexes like Germany's DAX and France's CAC 40 posting gains, investors are increasingly optimistic about the eurozone economy. In this environment of cautious optimism, dividend stocks can offer a compelling opportunity for income-focused investors seeking stability and potential returns; these stocks typically provide regular payouts that...
OM:ASKER
OM:ASKERHealthcare

Asker Healthcare Group (OM:ASKER) Earnings Surge Tests Premium P/E And Margin Concerns

Asker Healthcare Group (OM:ASKER) FY 2025 Results Snapshot Asker Healthcare Group (OM:ASKER) has wrapped up FY 2025 with fourth quarter revenue of SEK4.7 billion and basic EPS of 0.34 SEK, setting the tone for how investors assess the full year. Over recent periods, the company has seen quarterly revenue move from SEK4.3 billion and EPS of 0.24 SEK in Q4 2024 to SEK4.7 billion and EPS of 0.34 SEK in Q4 2025. Trailing twelve month EPS came in at 1.25 SEK on revenue of SEK16.8 billion, giving...
OM:ALIG
OM:ALIGMachinery

Alimak Group (OM:ALIG) Margin Improvement To 9.9% Tests Bullish Growth Narratives

Alimak Group (OM:ALIG) has wrapped up FY 2025 with fourth quarter revenue of SEK 1,692 million and basic EPS of SEK 0.98, setting the tone for how investors will parse the full year. The company has seen quarterly revenue move between SEK 1,658 million and SEK 1,791 million through 2025, with EPS ranging from SEK 0.98 to SEK 1.74. Trailing twelve month EPS for the period ended Q4 2025 is SEK 5.71. With trailing net margin at 9.9% and recent earnings growth in the backdrop, this latest print...
OM:NYAB
OM:NYABConstruction

February 2026's Undervalued Small Caps With Insider Action In Global Markets

In February 2026, global markets are experiencing a dynamic shift as small-cap and value-oriented stocks make gains amid a cooling U.S. labor market and volatility in large-cap technology shares. With the S&P MidCap 400 and Russell 2000 indices showing solid performance, investors are increasingly interested in small-cap opportunities that demonstrate resilience and potential for growth. In this context, identifying a good stock often involves looking at companies with strong fundamentals...